You are here

  • Home
  • Archive
  • Volume 80, Issue 5
  • Response to: ‘Correspondence on Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab’ by Messina et al

Citation Tools

Article menu
Download PDFPDF
Correspondence response
Response to: ‘Correspondence on Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab’ by Messina et al

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Duret P, Spielmann L, Messer L
Response to: ‘Correspondence on Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab’ by Messina et al
Annals of the Rheumatic Diseases 2021;80:e80.